Atlas Trials

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Clinical trial NCT01318941 · COMPLETED

Trial details

NCT number
NCT01318941
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Study type
OBSERVATIONAL
Wet Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein OcclusionWet Age Related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
Start date
2011-03-01
Primary completion
2016-04-01
Enrollment
30490

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.